Morning The.Italian.
I see DVP has declined nearly 30% in the last 6 to 7 weeks which I guess is due to Chinas recent financials
Interims tomorrow. Will be an interesting read with, I suspect, many excuses.
FUMs product appears to be selling like hot cakes. I recently bought back in as I felt it had gone as low as it could with sales figures expected soon.
I for one am anxious about the FDA since incompetence rules. One just has to reread all the announcements and emails received where lies have been openly made and miss information passed on to understand what a complete cokc-up the company has made regarding the approval process which leave me with the bad taste that they may have missed the boat.
The Chinese approval process, however, is going according to plan as the process has no connection with the monkeys running the company. I fully expect approval mid next year.
That said, I fully expect another cash call with further dilution as they will have no money, yet again, come the end of the year. A totally unnecessary requirement if they had gotten their act together several years back. What a complete disaster management have been. Led by a chairman who has absolutely no business sense in this area. A person who should have replaced the bod and ceo with experienced and competence people from the very beginning.
Morning The.Italian,
I’m afraid it’s going to be flip of the coin on FDA news. Something certainly doesn’t seem right. It really shouldn’t be taking this long. It’s not like the FDA has reams of data to go through. Just less than 90 subject data, yet 5 plus years to pass the phase II finish and its still not done, sumfings up
And still no update or obvious progress on the FDA submission which is still stuck on Sept 22. Another few weeks and it will be over a year since the results were first submitted. What a debacle it has been from the start.
https://classic.clinicaltrials.gov/ct2/show/NCT03578783
I notice the gov website for the phase 3 is now showing completed. it was only a month or two ago, last time I looked, that it wasn't showing phase III as fully "completed" but instead had some other dialogue there (cannot remember what was written but i know it wasn't just the one word "completed" as per now)
http://www.chinadrugtrials.org.cn/clinicaltrials.searchlist.dhtml
Seems progress is still being made. Maybe that's what caused the recent interest ?
Finally after years of realisation that she has no experience in Pharma, Julie Oates has left to get her Oats elsewhere, although god knows what she did in the company apart from get paid.
And what do they do with an opportunity to right their wrongs and employ someone with relevant background, they employ someone with a mainly engineering background who’s names resembles a bottle of wine, Al Chalabi.
What’s the matter with these people ? Surely they must have realised by now the company desperately needs talent with Pharma experience. Maybe they employed him because they think the company is going to fly after Chinese submission……oh dear, oh dear….
H,
I certainly am not an HSBC trader, in fact nothing to do with my profession when I worked. Pure guesswork on your side I’m afraid, but all means keep trying.
Amazingly, it was up over 25% and a couple of 10single lot sells brings it back down with a thump. At least the sp managed to hold on to 11%.
Could this just be a low volume pump and dump (if there is such a thing) heading into the mid term results, what say you H ?
The.Italian,
You were not wrong. A sudden rise and right on cue, Heimdal enters stage left.
Let’s all give it up for Heimdal…clap, clap, clap….hoooorrraaahhh.
Ripely,
You may want to consider dipping a toe in FUM since their mid-term results are due in Sept which could give a sudden boost, although maybe risky given the US license agreement held no juice, however. One would expect in the long term the sp could do well as more license agreements are signed and first impressions are that the product is definitely giving Viagra and Cialis a run for their money which, in a multi-billion dollar market, cannot be ignored.
Morning The.Italian.
No problem, the guy obviously hasn't read any of your posts. He doesn't even know if you are supposedly ramping or deramping. A complete dcik
Ripely, there are no other less experienced investors who post here. The only ones who do are hardened investors (except 1) who have followed the stock since the Ple takeover at the beginning of 2016. The majority of investors outside of the A team are those residing in HK or mainland China and then those that have posted here have turned out to be English speaking HK traders who think they can manipulate the stock when they are involved in pumps and dumps, however. Given how the free float is now a lot less, I would suspect that it’s become more difficult for them to even do that.
Toli,
So his 6,936 have all been posts about FUM. A share he has never been invested in? I suggest you go away and do some homework before posting such absurd statements otherwise you will just show yourself to be completely incompetent.
That should read as “Would not want to attract attention”.
Morning The.Italian,
It is anyone's guess given past history, however. Since it has basically risen everyday for the last week. One cannot ignore some news has been leaked, particularly since only small volumes are involved. This certainly could support positive news because any one buying would want to attract attention to themselves with reduced free float of shares and the consequences of significant rises on any large buys. All speculation on my part, but something is a foot.
I see Saudi may have received approval for Eroxon, although there doesn't appear to be an RNS about it yet. The SP certainly appears to being held back. With the recent news one would still expect a small rise instead of stagnation.
Well a 10k share sell and up she pops 11%. It would seem the current level is around 1 HK Dorrar.....lol.
There has got to be news released soon...... even bad news, although from the recent rise, it surely has to be good. :-)
Probably why it’s still not on sale in China where there are between 175 to 200 mill sufferers. The market cap would be much higher if they had gotten approval which surely wouldn’t take 2 years when no drugs are involved.
Well someone must be kicking themselves as it closed abt 18.5% lower than they paid. Certainly not conducive to make new investors jump in. Of course, whoever it was will still make money on the news, but they could have been 18% better off……lol
I should think definitely China approval next year, however. I wouldn't bet my life on FDA approval in the next couple of years given the historic incompetence of those involved. Of course, my view could possibly change if the reigns of the approval process were handed over to a licensee with clout, but given no one has wanted to commit after all these years of allusions, why would it be any different now, even with a SPA. It's not like the sales exercise did anything to help, did it ?
Granted. One could argue some of it was under the Endurance heading, however. It was all initiated by Regent who just passed the hat and have taken it back again....